NTLA
Price
$22.55
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
43 days until earnings call
SEER
Price
$1.72
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
48 days until earnings call
Ad is loading...

NTLA vs SEER

Header iconNTLA vs SEER Comparison
Open Charts NTLA vs SEERBanner chart's image
Intellia Therapeutics
Price$22.55
Change-$0.00 (-0.00%)
Volume$1.47M
CapitalizationN/A
Seer
Price$1.72
Change-$0.00 (-0.00%)
Volume$450.83K
CapitalizationN/A
View a ticker or compare two or three
NTLA vs SEER Comparison Chart
Loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SEER
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
NTLA vs. SEER commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a Hold and SEER is a StrongBuy.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (NTLA: $22.55 vs. SEER: $1.72)
Brand notoriety: NTLA and SEER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTLA: 113% vs. SEER: 132%
Market capitalization -- NTLA: $2.29B vs. SEER: $103.2M
NTLA [@Biotechnology] is valued at $2.29B. SEER’s [@Biotechnology] market capitalization is $103.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $609.91B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 0 FA rating(s) are green whileSEER’s FA Score has 1 green FA rating(s).

  • NTLA’s FA Score: 0 green, 5 red.
  • SEER’s FA Score: 1 green, 4 red.
According to our system of comparison, SEER is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 5 TA indicator(s) are bullish while SEER’s TA Score has 4 bullish TA indicator(s).

  • NTLA’s TA Score: 5 bullish, 3 bearish.
  • SEER’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than SEER.

Price Growth

NTLA (@Biotechnology) experienced а +12.08% price change this week, while SEER (@Biotechnology) price change was +8.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.17%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was -2.02%.

Reported Earning Dates

NTLA is expected to report earnings on Oct 31, 2024.

SEER is expected to report earnings on Nov 05, 2024.

Industries' Descriptions

@Biotechnology (+1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($2.29B) has a higher market cap than SEER($103M). SEER YTD gains are higher at: -11.340 vs. NTLA (-26.041). SEER has higher annual earnings (EBITDA): -94.34M vs. NTLA (-514.18M). NTLA has more cash in the bank: 691M vs. SEER (283M). SEER has less debt than NTLA: SEER (27.1M) vs NTLA (106M). NTLA has higher revenues than SEER: NTLA (46M) vs SEER (14M).
NTLASEERNTLA / SEER
Capitalization2.29B103M2,224%
EBITDA-514.18M-94.34M545%
Gain YTD-26.041-11.340230%
P/E RatioN/AN/A-
Revenue46M14M329%
Total Cash691M283M244%
Total Debt106M27.1M391%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
92
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTLASEER
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SEER
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LSVGX15.140.06
+0.40%
LSV Global Value Institutional
GSINX23.35N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps Inv
OIRDX28.13-0.04
-0.14%
Invesco Rising Dividends R6
AWPCX16.79-0.06
-0.36%
AB Sustainable Intl Thematic C
DRLAX9.24-0.06
-0.65%
BNY Mellon Developed Markets RE Scs - A

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with BEAM. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+4.83%
BEAM - NTLA
76%
Closely correlated
-0.16%
EDIT - NTLA
74%
Closely correlated
+0.78%
CRSP - NTLA
71%
Closely correlated
+4.46%
VCYT - NTLA
69%
Closely correlated
+2.05%
PRME - NTLA
68%
Closely correlated
+6.95%
More

SEER and

Correlation & Price change

A.I.dvisor indicates that over the last year, SEER has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SEER jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SEER
1D Price
Change %
SEER100%
+2.38%
AXON - SEER
56%
Loosely correlated
-0.83%
INZY - SEER
49%
Loosely correlated
-2.67%
NTLA - SEER
49%
Loosely correlated
+4.83%
PRME - SEER
48%
Loosely correlated
+6.95%
ARRY - SEER
47%
Loosely correlated
+3.30%
More